New Delhi metallo-β-lactamase 1.
暂无分享,去创建一个
[1] N. Woodford,et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.
[2] P. Hawkey,et al. The changing epidemiology of resistance. , 2009, The Journal of antimicrobial chemotherapy.
[3] Timothy R. Walsh,et al. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.
[4] Ronald N. Jones,et al. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] T. Johnson,et al. Plasmid Replicon Typing of Commensal and Pathogenic Escherichia coli Isolates , 2007, Applied and Environmental Microbiology.
[6] K. Kusza,et al. Antimicrobial susceptibility of metallo-beta-lactamase positive and negative Klebsiella pneumoniae strains isolated from intensive care unit patients. , 2010, Polish journal of microbiology.
[7] P. Nordmann,et al. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. , 2009, The Lancet. Infectious diseases.
[8] A. Antoniadou,et al. In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals , 2006, Antimicrobial Agents and Chemotherapy.
[9] K. Bush,et al. Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.
[10] A. Peleg,et al. Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Y. Carmeli,et al. Treatment with Fluoroquinolones or with β-Lactam-β-Lactamase Inhibitor Combinations Is a Risk Factor for Isolation of Extended-Spectrum-β-Lactamase-Producing Klebsiella Species in Hospitalized Patients , 2010, Antimicrobial Agents and Chemotherapy.
[12] A. Armaganidis,et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. , 2007, The Journal of antimicrobial chemotherapy.
[13] Y. Ishii,et al. Nosocomial outbreak of genetically related IMP-1 beta-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan. , 2007, International journal of antimicrobial agents.
[14] John Quale,et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. , 2005, Archives of internal medicine.
[15] Richard A. Moore,et al. Nosocomial Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa with a New blaIMP Allele, blaIMP-7 , 2002, Antimicrobial Agents and Chemotherapy.
[16] F. Kapadia,et al. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. , 2010, The Journal of the Association of Physicians of India.